Related Experiment Video
Updated: Jun 28, 2026

Color Spot Test As a Presumptive Tool for the Rapid Detection of Synthetic Cathinones
Published on: February 5, 2018
Dextromethorphan.
Joseph A Banken1, Howell Foster
1College of Medicine, Department of Obstetrics and Gynecology, Antenatal and Neonatal Guidelines, Education and Learning System (ANGELS), University of Arkansas for Medical Sciences, Little Rock, Arkansas, USA. BankenJosephA@uams.edu
Dextromethorphan (DXM) is increasingly abused, especially in rural areas. This review examines DXM abuse trends using national and poison control center data, highlighting its emerging role as a drug of abuse.
Area of Science:
- Pharmacology
- Toxicology
- Public Health
Background:
- Dextromethorphan (DXM) is an over-the-counter cough suppressant.
- Emerging evidence suggests widespread abuse of DXM in various formulations.
- Co-ingredients in over-the-counter (OTC) products may contribute to adverse effects.
Purpose of the Study:
- To review the role of dextromethorphan as an emerging drug of abuse.
- To discuss the effects of dextromethorphan and its co-ingredients.
- To explore national trends and implications of DXM abuse.
Main Methods:
- Analysis of Drug Abuse and Warning Network (DAWN) national data.
- Examination of data from poison control centers, including the Arkansas Poison Control Center (APCC).
- Postulation of possible national trends in dextromethorphan abuse.
Main Results:
- Dextromethorphan abuse is an emerging trend.
- Data from APCC indicate a particular rise in abuse within a rural US area.
- Abuse involves dextromethorphan and potentially other ingredients in OTC formulations.
Conclusions:
- Dextromethorphan represents a growing public health concern due to its abuse potential.
- Poison control center data are crucial for identifying and monitoring emerging drug abuse trends.
- Further research and public health interventions are needed to address dextromethorphan abuse.
More Related Videos
Related Concept Videos
Upper Respiratory Drugs: Antitussives, Expectorants, and Mucolytics
Antitussives include codeine, dextromethorphan (Robitussin), and benzonatate (Tessalon). Codeine and dextromethorphan exert their effects centrally by suppressing the cough reflex center in the medulla. Benzonatate operates peripherally within the respiratory tract by anesthetizing...
Adrenergic Agonists: Mixed-Action Agents
Ephedrine and pseudoephedrine lack a catecholamine group, making them less susceptible to degradation by metabolic enzymes. They have increased oral bioavailability and lipophilicity, resulting in a longer duration of action. Their response is reduced by...
Upper Respiratory Drugs: Decongestants
Most decongestants are readily available over-the-counter in various...
Drugs Used in Upper Respiratory Disorders: Overview
Antihistamines (e.g., Benadryl) block histamines from binding. Histamines are chemicals released during an allergic reaction in the body. As a...
Antiasthma Drugs: Methylxanthines
Theophylline is thought to inhibit phosphodiesterase enzymes, increasing intracellular levels of cyclic adenosine monophosphate (cAMP) and cyclic guanosine monophosphate (cGMP). This rise in cAMP and cGMP concentrations stimulates cardiac function,...
Sedatives and Hypnotics Drugs: Miscellaneous Agents
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...

